It is my pleasure to welcome back Dr. Shannon Hader to CDC. Starting October 6th, Dr. Hader will serve as the new Director of the Division of Global HIV/AIDS (DGHA) in the Center for Global Health. Dr. Hader brings to CDC an extensive background in domestic and international HIV/AIDS. Specifically, she has worked in challenging socio-economic and political environments from rural Mississippi to rural Russia, and has emphasized accountability, scale and impact for sustainable responses from Washington, D.C. to Zimbabwe.
Dr. Hader began her career at CDC in 1999 as an epidemic intelligence service officer in the Division of HIV/AIDS Prevention. Since then, she has served in key health leadership roles both internationally and domestically. As a Commander in the Commissioned Corps of the U.S. Public Health Service, assigned to CDC, she worked as a medical epidemiologist for the Division of HIV/AIDS Prevention, CDC Country Director and DGHA lead in Zimbabwe, and senior scientific advisor to the President’s Emergency Plan for AIDS Relief (PEPFAR) at the Office of Global AIDS Coordinator. In 2007, she left the Federal Government to work for the District of Columbia Department of Health, where she served as the director of the HIV/AIDS, Hepatitis, STD, and TB Administration for three years.
Dr. Hader comes to DGHA from Futures Group, where she served as Vice President and Director for the Center for Health Systems and Solutions. In addition to her work at Futures Group, Dr. Hader spent the past year as a Robert Wood Johnson Foundation Health Policy Fellow, where she served on the health policy staff of Senator Edward J. Markey of Massachusetts, chair of the Sub-committee on International Development and Foreign Assistance, Economic Affairs, International Environmental Protection, and Peace Corps, of the Senate Foreign Relations Committee.
Board-certified in Internal Medicine, Pediatrics, and Infectious Diseases, Dr. Hader earned her medical degree and master of public health from Columbia University and her BS in biological sciences from Stanford University. She completed a combined medicine/pediatrics residency at Duke University, and an infectious diseases fellowship at Emory University. She has served as a clinical assistant professor of medicine at Emory University, and was a Katherine Houghton Hepburn Fellow at Bryn Mawr College.
I would also like to take this opportunity to thank Dr. John Blandford for serving as Acting Director of DGHA since April 2014. John demonstrated exemplary leadership and made significant contributions to the Division while in his role as Acting Director, successfully guiding CDC’s response to strategic shifts in the PEPFAR program and playing a key role in shaping the Division’s human rights agenda. We are incredibly appreciative of John for his dedicated service to the Division.
Please join me in welcoming and supporting Dr. Hader in her new role at DGHA as well as thanking John for his outstanding leadership as the acting Division Director.Kind regards,
Tom Kenyon MD MPH
Center for Global Health